The global weight loss therapeutics market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing obesity rates and rising awareness about the benefits of weight loss therapeutics. The demand for weight loss therapeutics is also increasing due to their effectiveness in reducing body fat and improving metabolic health.
The global weight loss therapeutics market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into appetite suppression drugs, drugs that increase body metabolism, and drugs that interfere with digestion absorption patterns. On the basis of application, it can be divided into hospitals & clinics (specialized), retail pharmacies (mail order), and others (specialty stores). On the basis of region it can be divided into North America (NA), Latin America (LA), Europe (EU), Asia Pacific & Middle East & Africa(APMEA).
Some Of The Growth Factors Of This Market:
- The global obesity epidemic is a major factor in the growth of the weight loss therapeutics market.
- The increasing prevalence of chronic diseases such as diabetes and cardiovascular disease is also driving the growth of this market.
- Increasing awareness about weight management and obesity among consumers is also a key factor driving this market's growth.
- The rising incidence of lifestyle-related diseases such as hypertension, high cholesterol, and type 2 diabetes are also contributing to the growth of this market.
- Increasing demand for weight loss products from emerging markets such as China, India, Brazil, Mexico and Russia are also contributing to the growth of this market.
Industry Growth Insights published a new data on “Weight Loss Therapeutics Market”. The research report is titled “Weight Loss Therapeutics Market research by Types (Appetite Suppression, Increasing Body Metabolism, Interfering with the Digestion Absorption Patterns), By Applications (Hospitals, Specialized Clinics, Retail Pharmacies, Mail Order Pharmacies, Others), By Players/Companies Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG, Biocon, VIVUS, Eli Lilly, Amgen, Zafgen, Roche, Eisai”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Weight Loss Therapeutics Market Research Report
By Type
Appetite Suppression, Increasing Body Metabolism, Interfering with the Digestion Absorption Patterns
By Application
Hospitals, Specialized Clinics, Retail Pharmacies, Mail Order Pharmacies, Others
By Companies
Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG, Biocon, VIVUS, Eli Lilly, Amgen, Zafgen, Roche, Eisai
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Weight Loss Therapeutics Market Report Segments:
The global Weight Loss Therapeutics market is segmented on the basis of:
Types
Appetite Suppression, Increasing Body Metabolism, Interfering with the Digestion Absorption Patterns
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialized Clinics, Retail Pharmacies, Mail Order Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Sanofi
- Novo Nordisk
- Arena Pharmaceuticals
- Orexigen Therapeutics
- Johnson & Johnson
- Pfizer
- Novartis AG
- Biocon
- VIVUS
- Eli Lilly
- Amgen
- Zafgen
- Roche
- Eisai
Highlights of The Weight Loss Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Appetite Suppression
- Increasing Body Metabolism
- Interfering with the Digestion Absorption Patterns
- By Application:
- Hospitals
- Specialized Clinics
- Retail Pharmacies
- Mail Order Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Weight Loss Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Weight loss therapeutics is a term used to describe any type of treatment or intervention for weight loss. This can include diet, exercise, medications, and surgery.
Some of the key players operating in the weight loss therapeutics market are Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG, Biocon, VIVUS, Eli Lilly, Amgen, Zafgen, Roche, Eisai.
The weight loss therapeutics market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Weight Loss Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Weight Loss Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Weight Loss Therapeutics Market - Supply Chain
4.5. Global Weight Loss Therapeutics Market Forecast
4.5.1. Weight Loss Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Weight Loss Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Weight Loss Therapeutics Market Absolute $ Opportunity
5. Global Weight Loss Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Weight Loss Therapeutics Market Size and Volume Forecast by Type
5.3.1. Appetite Suppression
5.3.2. Increasing Body Metabolism
5.3.3. Interfering with the Digestion Absorption Patterns
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Weight Loss Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Weight Loss Therapeutics Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Specialized Clinics
6.3.3. Retail Pharmacies
6.3.4. Mail Order Pharmacies
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Weight Loss Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Weight Loss Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Weight Loss Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Weight Loss Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Weight Loss Therapeutics Demand Share Forecast, 2019-2026
9. North America Weight Loss Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Weight Loss Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Weight Loss Therapeutics Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Specialized Clinics
9.4.3. Retail Pharmacies
9.4.4. Mail Order Pharmacies
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Weight Loss Therapeutics Market Size and Volume Forecast by Type
9.7.1. Appetite Suppression
9.7.2. Increasing Body Metabolism
9.7.3. Interfering with the Digestion Absorption Patterns
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Weight Loss Therapeutics Demand Share Forecast, 2019-2026
10. Latin America Weight Loss Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Weight Loss Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Weight Loss Therapeutics Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Specialized Clinics
10.4.3. Retail Pharmacies
10.4.4. Mail Order Pharmacies
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Weight Loss Therapeutics Market Size and Volume Forecast by Type
10.7.1. Appetite Suppression
10.7.2. Increasing Body Metabolism
10.7.3. Interfering with the Digestion Absorption Patterns
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Weight Loss Therapeutics Demand Share Forecast, 2019-2026
11. Europe Weight Loss Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Weight Loss Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Weight Loss Therapeutics Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Specialized Clinics
11.4.3. Retail Pharmacies
11.4.4. Mail Order Pharmacies
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Weight Loss Therapeutics Market Size and Volume Forecast by Type
11.7.1. Appetite Suppression
11.7.2. Icreasing Body Metabolism
11.7.3. Interfering with the Digestion Absorption Patterns
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Weight Loss Therapeutics Demand Share, 2019-2026
12. Asia Pacific Weight Loss Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Weight Loss Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Weight Loss Therapeutics Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Specialized Clinics
12.4.3. Retail Pharmacies
12.4.4. Mail Order Pharmacies
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Weight Loss Therapeutics Market Size and Volume Forecast by Type
12.7.1. Appetite Suppression
12.7.2. Increasing Body Metabolism
12.7.3. Interfering with the Digestion Absorption Patterns
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Weight Loss Therapeutics Demand Share, 2019-2026
13. Middle East & Africa Weight Loss Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Weight Loss Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Weight Loss Therapeutics Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Specialized Clinics
13.4.3. Retail Pharmacies
13.4.4. Mail Order Pharmacies
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Weight Loss Therapeutics Market Size and Volume Forecast by Type
13.7.1. Appetite Suppression
13.7.2. Increasing Body Metabolism
13.7.3. Interfering with the Digestion Absorption Patterns
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Weight Loss Therapeutics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Weight Loss Therapeutics Market: Market Share Analysis
14.2. Weight Loss Therapeutics Distributors and Customers
14.3. Weight Loss Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novo Nordisk
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Arena Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Orexigen Therapeutics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pfizer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Novartis AG
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biocon
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. VIVUS
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Eli Lilly
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Amgen
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Zafgen
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Roche
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Eisai
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
